CI

At a glance

ClinicalIndex Comparison Record
Phase 2Completed· 35 enrolled
Drug / intervention
AN2728 +1 moredrug
Likely dose
Not stated in record
Structured eligibility isn't available for this trial yet — see the full criteria in the Eligibility tab below.

Standardized by ClinicalIndex from the ClinicalTrials.gov record · verify against the source.

Search/NCT00759161
NCT00759161Phase 2Completed
CompareCT.gov

A Double-Blind, Randomized Bilateral Study of the Safety and Efficacy of AN2728 Ointment, 5%, Versus Ointment Vehicle in the Treatment of Patients With Plaque Type Psoriasis

Pfizer·interventional·Posted Sep 25, 2008·Updated Mar 6, 2017

In Brief

A Phase 2 clinical trial evaluating AN2728 and AN2728 Ointment Vehicle for Psoriasis. Completed, enrolled 35 participants across 1 site.

Detailed Summary

The purpose of the study is to determine the safety and efficacy of AN2728 Ointment, 5%, compared to Ointment Vehicle in the treatment of plaque type psoriasis.

Study Details

Study Typeinterventional
Allocation--
Masking--
Primary Purpose--
ConditionsPsoriasis
CountriesMexico
Collaborators--

Timeline

Phase 2CompletedFinished
20082009201020112012201320142015201620172018201920202021202220232024202520262027
First PostedSep 25, 2008
Enrollment StartNov 1, 2007
Primary CompletionMar 1, 2008
TodayJul 2, 2026
Enrollment to primary: 4 monthsPosted 17.8 years ago

Interventions

AN2728drug

AN2728 Ointment, 5%, twice daily for 4 weeks

AN2728 Ointment Vehicledrug

AN2728 Ointment Vehicle, twice daily for 4 weeks.